November 15, 2012
A New York federal judge on Wednesday threw out an 8-year-old False Claims Act suit from a former Pfizer Inc. medical director claiming the company engaged in off-label marketing of its statin Lipitor, ruling that federal cholesterol guidelines are meant to be advisory rather than restrictive limitations.
May 27, 2009
A federal judge has dismissed whistleblower claims filed by a former medical director at Pfizer Inc. over the company's alleged off-label marketing of its statin Lipitor, but has allowed the doctor's claims for retaliation to go forward.